- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 183
Lycia Pharmaceuticals rakes in $70m
Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.
Sep 13, 2021Corporates swoop in for Skydweller’s $40m series A
Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.
Sep 13, 2021Analysis: PayPal pays $2.7bn to Paidy
PayPal is to purchase its portfolio company Paidy, a consumer finance service provider. Paidy is part of the wider payment tech space, which has seen an increasing number of exits since last year.
Sep 13, 2021Daily Deal Round Up: September 10, 2021
Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.
Sep 10, 2021Daily deal net: September 10, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 10, 2021Penn produces iEcure with $50m
Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.
Sep 10, 2021Varo Bank cashes in with $510m round
The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.
Sep 10, 2021Allianz waves AV8 Ventures to $180m fund
Allianz has recommitted to the venture capital firm having funded its $170m debut vehicle two years ago.
Sep 10, 2021Packable goes for $1.55bn reverse merger
Reckitt Benckiser, Emerson Group, McKesson and Sealed Air are set to score exits from the e-commerce services provider.
Sep 10, 2021Mammoth Biosciences raises $195m across two rounds
Disease diagnostics technology developer Mammoth Biosciences is valued at over $1bn following funding rounds backed by investors including Amazon.
Sep 10, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


